Over-The-Counter Human Drugs; Proposed Labeling Requirements; Notice of Availability of Study Data and Reopening of Comment Period

Короткий зміст

The Food and Drug Administration (FDA) is reopening to February 13, 1998 the comment period on specific data related to the February 27, 1997, proposed rule to establish a standardized format for the labeling of over-the-counter (OTC) drug products (62 FR 9024). As part of that rulemaking proceeding, the agency collected data under a study entitled ``Over-the-Counter (OTC) Label Format Preference, Study B.'' (Study B). This document announces the availability of the data and frequency tabulations that summarize the Study B data and reopens the comment period for the OTC rulemaking proceeding to allow an opportunity for comment on Study B.